Epidemiology and natural history of inflammatory bowel diseases.

By J. Cosnes, C. Gower‐Rousseau, P. Seksik, A. Cortot. Gastroenterology, 2011

2,111 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. (2013, background): “In high-incidence areas, UC occurs more frequently in men and CD occurs 20% 30% more frequently in females, although in low-incidence areas CD has been reported more frequently in men, as in our study.(2,4) We have also shown that Asian patients with IBD have less familial clustering (only 3%).”
Obesity in autoimmune diseases: not a passive bystander. (2014, background): “The prevalence of IBD has increased mainly in Western countries in the past 50 years up to 120–200/100,000 and 50–200/100,000 for UC and CD respectively [166].”
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment (2012, background): “The former is confined to the colon, while the latter may affect any part of the digestive tract, with unclear implications for microbial involvement or causality [2].”
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases (2019, background): “prausnitzii), increases luminal content of butyrate (green), propionate (blue) and acetate (purple) (2), forming a gradient along the crypt.”